VanEck Biotech ETF (NASDAQ:BBH) Shares Purchased by Flagship Harbor Advisors LLC

Flagship Harbor Advisors LLC lifted its holdings in VanEck Biotech ETF (NASDAQ:BBH) by 12.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,984 shares of the company’s stock after acquiring an additional 214 shares during the period. Flagship Harbor Advisors LLC’s holdings in VanEck Biotech ETF were worth $311,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in BBH. Jane Street Group LLC boosted its holdings in VanEck Biotech ETF by 401.7% in the 3rd quarter. Jane Street Group LLC now owns 8,348 shares of the company’s stock worth $1,481,000 after acquiring an additional 6,684 shares during the period. Truist Financial Corp grew its holdings in VanEck Biotech ETF by 3.8% during the 2nd quarter. Truist Financial Corp now owns 2,703 shares of the company’s stock valued at $455,000 after purchasing an additional 100 shares in the last quarter. Northwestern Mutual Wealth Management Co. grew its holdings in VanEck Biotech ETF by 5.8% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 24,324 shares of the company’s stock valued at $4,096,000 after purchasing an additional 1,334 shares in the last quarter. Kovitz Investment Group Partners LLC increased its stake in VanEck Biotech ETF by 4.6% during the 3rd quarter. Kovitz Investment Group Partners LLC now owns 3,186 shares of the company’s stock worth $565,000 after buying an additional 141 shares during the period. Finally, International Assets Investment Management LLC lifted its holdings in VanEck Biotech ETF by 10,376,390.9% in the 3rd quarter. International Assets Investment Management LLC now owns 1,141,414 shares of the company’s stock worth $202,475,000 after buying an additional 1,141,403 shares in the last quarter. Hedge funds and other institutional investors own 32.05% of the company’s stock.

VanEck Biotech ETF Stock Performance

Shares of VanEck Biotech ETF stock opened at $163.52 on Thursday. VanEck Biotech ETF has a 1-year low of $151.35 and a 1-year high of $183.64. The business has a 50-day moving average of $161.89 and a 200-day moving average of $171.05.

VanEck Biotech ETF Dividend Announcement

The firm also recently disclosed a dividend, which was paid on Tuesday, December 24th. Shareholders of record on Monday, December 23rd were paid a dividend of $1.2517 per share. The ex-dividend date of this dividend was Monday, December 23rd.

About VanEck Biotech ETF

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.